← All stocks

MANNKIND CORP

MNKD Net selling
CIK 0000899460 #2314 in the set updated 17 Sep 2026
Bought (120 mo)
$2.50M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$10.79M
$4.79M on a plan · $2.99M straight out of an exercise
Sold at will
$3.00M
17 of 59 sales
Net
−$8.29M
−$504.76K against sales at will

By person

26 insiders · 123 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Castagna Michael
Chief Executive Officer
$487.73K (19)
$4.37M (20)
−$3.88M
2,437,072
$9.29M
Binder Steven B.
Director
$19.17K (9)
$2.87M (15) scheduled
−$2.85M
752,309
$2.87M
Thomson David
EVP Genl Counsel & Secretary
$1.83M (14) scheduled
−$1.83M
797,554
$3.04M
+2,227%
Tross Stuart A
Chief People & Workpl Officer
$199.99K (11)
$1.61M (6) scheduled
−$1.41M
1,158,142
$4.41M
+4,333%
KRESA KENT
Director
$999.60K (1)
+$999.60K
512,130
$1.95M
+68.5%
Grancio Jennifer
Director
$300.00K (1)
+$300.00K
244,815
$932.75K
+100.5%
Galindo Alejandro
EVP Endocrine Business Unit
$237.00K (5)
$17.77K (2)
+$219.23K
777,075
$2.96M
+18,145%
HOOPER ANTHONY C
Director
$108.40K (1)
+$108.40K
236,153
$899.74K
+257.2%
Singh Sanjay R
EVP Technical Operations
$94.45K (1) scheduled
−$94.45K
478,966
$1.82M
+6,363%
MUNDKUR CHRISTINE
Director
$75.00K (1)
+$75.00K
254,493
$969.62K
+31.0%
McCauley Patrick
Chief Commercial Officer
$21.40K (4)
+$21.40K
83,972
$319.93K
Kendall David M
Chief Medical Officer
$17.34K (4)
+$17.34K
41,059
$156.43K
Barton Courtney
Chief Compl & Privacy Officer
$15.71K (3)
+$15.71K
29,584
$112.72K
+889.8%
Alinaya Rosabel Realica
VP, IR & Treasury
$7.34K (2)
+$7.34K
37,119
$141.42K
Ingram Elizabeth Garrett
Chief Marketing Officer
$5.35K (1)
+$5.35K
31,141
$118.65K
PFEFFER MATTHEW J
Director
$4.91K (2)
+$4.91K
81,961
$312.27K
+7.7%
Urbanski Raymond W.
Corp VP, CMO
$340.40 (1)
−$340.40
2,924
$11.14K
−9.2%
Kocinsky Joseph
Chief Technology Officer
745,233
$2.84M
+3,031%
BLANK BURKHARD
EVP Chief Medical Officer
460,791
$1.76M
+8,722%
Sabella Lauren M
EVP Operations
349,841
$1.33M
+8,898%
Marasco Dominic
Pres, Endocrine Business Unit
343,398
$1.31M
+6,610%
Prentiss Christopher B
Chief Financial Officer
318,668
$1.21M
+3,824%
Ahuja Ajay
Chief Medical Officer
318,200
$1.21M
Kay Sabrina
Director
265,600
$1.01M
+67.5%
Consiglio Ronald J
Director
132,342
$504.22K
+179.5%
Shannon James Samuel
Director
64,635
$246.26K
+22.8%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Castagna Michael
17 Dec 2025
Chief Executive Officer
Sold after exercise
65,804
$6.01
$395.48K
Castagna Michael
16 Dec 2025
Chief Executive Officer
Sold after exercise
21,310
$6.00
$127.86K
Castagna Michael
12 Dec 2025
Chief Executive Officer
Sold after exercise
20,806
$6.00
$124.84K
Thomson David
2 Dec 2025
EVP Genl Counsel & Secretary
Sold after exercise
147,780
$5.57
$823.13K
Castagna Michael
2 Dec 2025
Chief Executive Officer
Sold after exercise
107,920
$5.57
$601.11K
Binder Steven B.
22 Nov 2024
Director
Sold after exercise
67,536
$6.89
$465.32K
Binder Steven B.
15 Nov 2024
Director
Sold after exercise
67,539
$6.76
$456.56K

What was left out

Form 4 filings counted 389
Amendments (4/A) skipped 32
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 35
Sales straight out of an exercise 7
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 20,580,059
Sales filed before the plan box existed 6
History held since 31 Aug 2016